Literature DB >> 2730257

Risk factors for acquisition of gentamicin-resistant enterococci. A multivariate analysis.

P Axelrod1, G H Talbot.   

Abstract

High-level gentamicin resistance in enterococci is an increasing problem in hospitalized patients. Multiple risk factors for the acquisition of these organisms have been identified, but these risk factors are highly interrelated, and it has been unclear which of them are truly important. We performed a case-control study comparing 37 patients colonized or infected with resistant enterococci with 84 patients with susceptible strains. Crude odds ratios were significant for nosocomial acquisition, duration of hospitalization, hospitalization on the medical service or in an intensive care unit, number and duration of antibiotics received, and receipt of several individual antibiotics. By logistic regression, hospitalization longer than 2 weeks (odds ratio, 5.4; 95% confidence interval, 1.7 to 17) and receipt of five or more antibiotics (odds ratio, 26; 95% confidence interval, 2.8 to 250) were significantly associated with colonization or infection with resistant enterococci. Patients with these latter two risk factors may be targeted in infection control efforts.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2730257

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  7 in total

Review 1.  Virulence of enterococci.

Authors:  B D Jett; M M Huycke; M S Gilmore
Journal:  Clin Microbiol Rev       Date:  1994-10       Impact factor: 26.132

2.  Risk factors for acquisition of gentamicin-resistant enterococcal infection: a case-controlled study.

Authors:  M Viagappan; R E Holliman
Journal:  Postgrad Med J       Date:  1999-06       Impact factor: 2.401

3.  Bacteremia caused by hemolytic, high-level gentamicin-resistant Enterococcus faecalis.

Authors:  M M Huycke; C A Spiegel; M S Gilmore
Journal:  Antimicrob Agents Chemother       Date:  1991-08       Impact factor: 5.191

4.  Risk factors for acquiring ampicillin-resistant enterococci and clinical outcomes at a Canadian tertiary-care hospital.

Authors:  A E McCarthy; G Victor; K Ramotar; B Toye
Journal:  J Clin Microbiol       Date:  1994-11       Impact factor: 5.948

Review 5.  Infections due to antibiotic-resistant gram-positive cocci.

Authors:  G M Caputo; M Singer; S White; M R Weitekamp
Journal:  J Gen Intern Med       Date:  1993-11       Impact factor: 5.128

6.  Epidemiology of Enterococcus faecalis urinary tract infection in a teaching hospital in London, United Kingdom.

Authors:  L M Hall; B Duke; G Urwin; M Guiney
Journal:  J Clin Microbiol       Date:  1992-08       Impact factor: 5.948

7.  Risk factors for development of aminoglycoside resistance among gram-negative rods.

Authors:  Stefan E Richter; Loren Miller; Jack Needleman; Daniel Z Uslan; Douglas Bell; Karol Watson; Romney Humphries; James A McKinnell
Journal:  Am J Health Syst Pharm       Date:  2019-10-30       Impact factor: 2.637

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.